V. Kosse

Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.

D. Wallwiener, M. Untch, K. Possinger, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).

D. Wallwiener, M. Untch, K. Possinger, 2002, Anticancer research.

Impact of Lead on Reproductive Health of Men

V. Kosse, V. Shatorna, S. Ostrovska, 2021, Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.